BIO Bio-Rad Laboratories, Inc.

367.50USD-0.63%Mkt Cap: 9.88B USDP/E: 9.76

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates throug…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap9.88B USD
Enterprise Value9.65B USD
Revenue (TTM)2.59B USD
Gross Profit1.34B USD
Net Income (TTM)759.90M USD
Revenue/Share96.45 USD
Last Price367.50 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees7.5K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)9.76
P/E (Forward)37.10
PEG4.01
EV/EBITDA23.50
EV/Revenue3.72
P/S3.81
P/B1.30
EPS (TTM)37.64 USD
EPS (Forward)9.91 USD
52W Range
236.7382% of range396.23
52W High396.23 USD
52W Low236.73 USD
Profitability
Gross Margin51.87%
Oper. Margin9.46%
EBITDA Margin15.85%
Profit Margin29.42%
ROE10.20%
ROA7.18%
ROIC2.29%
ROCE2.17%
Growth
Revenue Growth0.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF532.20M USD
CapEx (TTM)157.60M USD
FCF Margin10.48%
FCF Yield2.75%
Net Debt-300.90M USD
Net Debt/EBITDA-0.73
Net Debt/FCF-1.11
Balance Sheet
Debt/Equity0.19
Current Ratio3.18
Quick Ratio2.16
Book Value/Sh282.74 USD
Cash/Share61.89 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateMar 8, 2002
Analyst Consensus
Rating3.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)356.67 USD
Upside (mean)-2.9%
Target Range280.00 USD – 440.00 USD
280.00-2.9% to mean440.00
# Analysts3
Ownership
Shares Out.21.83M
Float21.51M
Insiders16.29%
Institutions89.70%
Short Interest
Short Ratio5.1d
Short % Float7.21%
Short % Out.4.30%
Shares Short1.16M
Short (prev mo.)1.18M
Technical
SMA 50372.43 (-1.3%)
SMA 200317.32 (+15.8%)
Beta1.06
S&P 52W Chg12.08%
Avg Vol (30d)249.06K
Avg Vol (10d)278.23K
Technical Indicators
RSI (14)47.6
MACD-0.8616
MACD Signal0.7639
MACD Hist.-1.6254
BB Upper392.52 USD
BB Middle374.48 USD
BB Lower356.44 USD
BB Width9.64%
ATR (14)12.33 USD
Vol Ratio (20d)1.64x

About Bio-Rad Laboratories (NYSE: BIO)

›

Bio-Rad Laboratories (NYSE: BIO) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 7,450 employees.

The shares were at 367.50 USD on 19 November 2026, up 17.4% over 52 weeks. Its 52-week range is 236.73 USD to 396.23 USD: the price is 7.3% below the high and 55.2% above the low.

At a market capitalisation of 9.88B USD, it trades at 9.8 times trailing earnings and 37.1 times forward earnings. The median trailing P/E of its 18 largest Medical Devices peers is 26.3, a discount of 63% for BIO.

Bio-Rad Laboratories reports return on equity of 10.2%, an operating margin of 9.5% and revenue up 0.5% year over year.

It holds more cash than debt, a net cash position of 300.90M USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 3 analysts cover the stock, with an average rating of Hold; their mean price target of 356.67 USD is 2.9% below the current price. The next earnings report is expected on 11 February 2027.